We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
MIV Therapeutics and SagaX Medical Technologies announced that they have entered
into a letter of intent regarding SagaX's next generation embolic-protection
technology for stroke patients.
Novoste announced that its board of directors has determined that its vascular
brachytherapy (VBT) business is no longer viable and, as a result, has authorized
a staged, wind-down of the business.
LDR Spine, which has developed implantable systems that make it easier to perform
spine surgeries, has gotten clearance from the FDA to market two fusion spine
products in the U.S.
Tissue engineers can choose from a wide range of living cells, biomaterials
and proteins to repair a bone defect. But finding the optimum combination requires
improved methods for tracking the healing process.
Medical Carbon Research Institute (MCRI) has announced the approval of the On-X
Prosthetic Heart Valve by the Japanese Ministry of Health, Labor and Welfare.
CONMED has announced that its orthopedic business unit, ConMed Linvatec, a leader
in sports medicine technology, will be launching seven new products at the annual
conference of the American Academy of Orthopaedic Surgeons (AAOS) in Washington
D.C., Feb. 23-25.
Biosite, a research-based provider of novel, rapid medical diagnostics, announced
the FDA has notified the company that the agency has accepted the Triage Stroke
Panel premarket approval application (PMA) for further review.
CrossCart, a private medical device company focused on the development, manufacture
and commercialization of animal-derived tissue products for humans, has received
clearance from the FDA to initiate a pivotal trial for its lead product, a porcine-derived
ligament known as the Z-Lig.